Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-05-23 Purchase |
2022-05-25 5:12 pm |
ARCA biopharma Inc. | ABIO | Funicular Fund LP Ma-Weaver Jacob See Footnote 1 |
85,262 | $2.3153 | $197,404 | 2,594,952 (Direct) |
View |
| 2022-05-18 Purchase |
2022-05-20 6:01 pm |
ARCA biopharma Inc. | ABIO | Funicular Fund LP Ma-Weaver Jacob See Footnote 1 |
13,073 | $2.3046 | $30,128 | 2,509,690 (Direct) |
View |
| 2022-05-12 Purchase |
2022-05-16 7:31 pm |
ARCA biopharma Inc. | ABIO | Funicular Fund LP Ma-Weaver Jacob See Footnote 1 |
84,836 | $2.2884 | $194,143 | 2,496,617 (Direct) |
View |
| 2022-05-10 Purchase |
2022-05-11 6:38 pm |
ARCA biopharma Inc. | ABIO | Funicular Fund LP Ma-Weaver Jacob See Footnote 1 |
45,575 | $2.2848 | $104,128 | 2,411,781 (Direct) |
View |
| 2022-05-05 Purchase |
2022-05-09 5:44 pm |
ARCA biopharma Inc. | ABIO | Funicular Fund LP Ma-Weaver Jacob See Footnote 1 |
124,122 | $2.2765 | $282,563 | 2,366,206 (Direct) |
View |
| 2022-04-28 Purchase |
2022-05-02 7:03 pm |
ARCA biopharma Inc. | ABIO | Funicular Fund LP Ma-Weaver Jacob See Footnote 1 |
33,614 | $2.3124 | $77,730 | 2,242,084 (Direct) |
View |
| 2022-04-25 Purchase |
2022-04-27 6:33 pm |
ARCA biopharma Inc. | ABIO | Funicular Fund LP Ma-Weaver Jacob See Footnote 1 |
13,751 | $2.2913 | $31,508 | 2,208,470 (Direct) |
View |
| 2022-04-18 Purchase |
2022-04-20 7:43 pm |
ARCA biopharma Inc. | ABIO | Funicular Fund LP Ma-Weaver Jacob See Footnote 1 |
9,119 | $2.3117 | $21,080 | 2,187,219 (Direct) |
View |
| 2022-04-14 Purchase |
2022-04-14 8:04 pm |
ARCA biopharma Inc. | ABIO | Funicular Fund LP Ma-Weaver Jacob See Footnote 1 |
17,410 | $2.3289 | $40,546 | 2,171,100 (Direct) |
View |
| 2022-04-08 Purchase |
2022-04-12 7:31 pm |
ARCA biopharma Inc. | ABIO | Funicular Fund LP Ma-Weaver Jacob See Footnote 1 |
104,713 | $2.318 | $242,729 | 2,153,690 (Direct) |
View |
| 2022-04-05 Purchase |
2022-04-07 8:38 pm |
ARCA biopharma Inc. | ABIO | Funicular Fund LP Ma-Weaver Jacob See Footnote 1 |
103,984 | $2.3059 | $239,778 | 2,048,977 (Direct) |
View |
| 2022-04-04 Purchase(A) |
2022-04-07 8:36 pm |
ARCA biopharma Inc. | ABIO | Funicular Fund LP Ma-Weaver Jacob See Footnote 1 |
122,342 | $2.2585 | $276,309 | 1,944,993 (Direct) |
View |
| 2022-04-04 Purchase |
2022-04-04 8:26 pm |
ARCA biopharma Inc. | ABIO | Funicular Fund LP See Footnote 1 |
122,342 | $2.2585 | $276,309 | 1,944,993 (Direct) |
View |
| 2021-11-22 Purchase |
2021-11-23 4:53 pm |
ARCA biopharma Inc. | ABIO | Ozeroff Christopher David S.V.P., General Counsel |
50,000 | $2.2642 | $113,210 | 50,970 (Direct) |
View |
| 2021-05-12 Purchase |
2021-05-13 5:00 pm |
ARCA biopharma Inc. | ABIO | CONWAY ROBERT E Chairman of the Board |
10,000 | $3.1947 | $31,947 | 50,000 (Direct) |
View |
| 2021-05-05 Purchase |
2021-05-06 4:30 pm |
ARCA biopharma Inc. | ABIO | CONWAY ROBERT E Chairman of the Board |
10,000 | $3.2345 | $32,345 | 40,000 (Direct) |
View |
| 2020-12-18 Purchase |
2020-12-21 4:15 pm |
ARCA biopharma Inc. | ABIO | CONWAY ROBERT E Chairman of the Board |
10,000 | $4.163 | $41,630 | 30,000 (Direct) |
View |
| 2020-09-25 Purchase |
2020-09-25 4:20 pm |
ARCA biopharma Inc. | ABIO | CONWAY ROBERT E Chairman of the Board |
5,000 | $4.2799 | $21,399 | 20,000 (Direct) |
View |
| 2020-09-22 Purchase |
2020-09-24 4:20 pm |
ARCA biopharma Inc. | ABIO | CONWAY ROBERT E Chairman of the Board |
3,056 | $4.6599 | $14,241 | 15,000 (Direct) |
View |
| 2020-09-21 Purchase |
2020-09-21 5:00 pm |
ARCA biopharma Inc. | ABIO | CONWAY ROBERT E Chairman of the Board |
10,000 | $4.766 | $47,660 | 11,944 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2022-07-08 7:12 pm |
N/A N/A |
ARCA biopharma Inc. | ABIO | Funicular Funds LP See Footnote 1 10% Owner |
0 | $0 | 4,030,452 (Indirect) |
View |
| 2022-06-15 Option Award |
2022-06-21 7:42 pm |
N/A 2032-06-15 |
ARCA biopharma Inc. | ABIO | Ma-Weaver Jacob See Footnote 1 10% Owner |
12,000 | $0 | 4,042,452 (Direct) |
View |
Ownership |
2022-06-21 7:40 pm |
N/A N/A |
ARCA biopharma Inc. | ABIO | Ma-Weaver Jacob See Footnote 1 10% Owner |
0 | $0 | 4,030,452 (Indirect) |
View |
Ownership(A) |
2022-04-07 8:33 pm |
N/A N/A |
ARCA biopharma Inc. | ABIO | Funicular Fund LP Ma-Weaver Jacob See Footnote 1 |
0 | $0 | 1,822,651 (Direct) |
View |
Ownership |
2022-04-04 8:22 pm |
N/A N/A |
ARCA biopharma Inc. | ABIO | Funicular Fund LP See Footnote 1 |
0 | $0 | 1,822,651 (Direct) |
View |
| 2021-12-14 Option Award |
2021-12-16 4:33 pm |
N/A 2031-12-14 |
ARCA biopharma Inc. | ABIO | Ozeroff Christopher David S.V.P., General Counsel |
27,500 | $0 | 78,470 (Direct) |
View |
| 2021-12-14 Option Award |
2021-12-16 4:32 pm |
N/A 2031-12-14 |
ARCA biopharma Inc. | ABIO | Keuer Thomas A Chief Operating Officer |
35,000 | $0 | 35,730 (Direct) |
View |
| 2021-12-14 Option Award |
2021-12-16 4:31 pm |
N/A 2031-12-14 |
ARCA biopharma Inc. | ABIO | Dekker C. Jeffrey Chief Financial Officer |
17,700 | $0 | 17,700 (Direct) |
View |
| 2021-12-14 Option Award |
2021-12-16 4:31 pm |
N/A 2031-12-14 |
ARCA biopharma Inc. | ABIO | BRISTOW MICHAEL R Pres. & Chief Executive Offic |
95,000 | $0 | 99,808 (Direct) |
View |
Ownership |
2021-05-11 4:35 pm |
N/A 2031-05-10 |
ARCA biopharma Inc. | ABIO | Dekker C. Jeffrey Chief Financial Officer |
0 | $0 | 55,000 (Direct) |
View |
| 2021-01-12 Option Award |
2021-01-13 7:07 pm |
N/A 2031-01-12 |
ARCA biopharma Inc. | ABIO | Hove Anders D Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2021-01-12 Option Award |
2021-01-13 7:06 pm |
N/A 2031-01-12 |
ARCA biopharma Inc. | ABIO | Woosley Raymond L. Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2021-01-12 Option Award |
2021-01-13 7:06 pm |
N/A 2031-01-12 |
ARCA biopharma Inc. | ABIO | Grais Linda Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2021-01-12 Option Award |
2021-01-13 7:05 pm |
N/A 2031-01-12 |
ARCA biopharma Inc. | ABIO | MITCHELL DANIEL J Director |
12,000 | $0 | 12,611 (Direct) |
View |
| 2021-01-12 Option Award |
2021-01-13 7:04 pm |
N/A 2031-01-12 |
ARCA biopharma Inc. | ABIO | CONWAY ROBERT E Chairman of the Board |
12,000 | $0 | 42,000 (Direct) |
View |
| 2020-12-21 Option Award |
2020-12-23 4:47 pm |
N/A 2030-12-21 |
ARCA biopharma Inc. | ABIO | Keuer Thomas A Chief Operating Officer |
70,000 | $0 | 70,730 (Direct) |
View |
| 2020-12-21 Option Award |
2020-12-23 4:15 pm |
N/A 2030-12-21 |
ARCA biopharma Inc. | ABIO | Ozeroff Christopher David S.V.P., General Counsel |
55,000 | $0 | 55,970 (Direct) |
View |
| 2020-12-21 Option Award |
2020-12-23 4:15 pm |
N/A 2030-12-21 |
ARCA biopharma Inc. | ABIO | BRISTOW MICHAEL R Pres. & Chief Executive Offic |
190,000 | $0 | 194,808 (Direct) |
View |
| 2020-12-21 Option Award |
2020-12-23 4:15 pm |
N/A 2030-12-21 |
ARCA biopharma Inc. | ABIO | Selby Brian L. VP, Finance |
55,000 | $0 | 55,000 (Direct) |
View |